"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
| Descriptor ID |
D012008
|
| MeSH Number(s) |
C23.550.291.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 19 | 19 |
| 1996 | 0 | 12 | 12 |
| 1997 | 0 | 16 | 16 |
| 1998 | 0 | 20 | 20 |
| 1999 | 0 | 13 | 13 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 15 | 15 |
| 2002 | 0 | 21 | 21 |
| 2003 | 0 | 24 | 24 |
| 2004 | 0 | 27 | 27 |
| 2005 | 0 | 18 | 18 |
| 2006 | 0 | 34 | 34 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 34 | 34 |
| 2009 | 0 | 25 | 25 |
| 2010 | 0 | 37 | 37 |
| 2011 | 0 | 38 | 38 |
| 2012 | 0 | 25 | 25 |
| 2013 | 0 | 46 | 46 |
| 2014 | 0 | 37 | 37 |
| 2015 | 0 | 38 | 38 |
| 2016 | 0 | 40 | 40 |
| 2017 | 0 | 41 | 41 |
| 2018 | 0 | 52 | 52 |
| 2019 | 0 | 49 | 49 |
| 2020 | 0 | 42 | 42 |
| 2021 | 0 | 38 | 38 |
| 2022 | 0 | 26 | 26 |
| 2023 | 0 | 26 | 26 |
| 2024 | 11 | 9 | 20 |
| 2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas. Blood Adv. 2025 Feb 25; 9(4):696-703.
-
Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025 Mar; 12(2):e200375.
-
Study of the Association Between Menarche and Disease Course in Pediatric Multiple Sclerosis. Neurology. 2025 Feb 25; 104(4):e210213.
-
The infected diabetic foot: Risk factors for re-infection after treatment for diabetic foot osteomyelitis. Wound Repair Regen. 2025 Jan-Feb; 33(1):e13246.
-
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry. 2024 Dec 16; 96(1):68-75.
-
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States. Prev Med. 2025 Jan; 190:108180.
-
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse. Haematologica. 2024 Nov 01; 109(11):3543-3556.
-
RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax. Nature. 2024 Dec; 636(8041):241-250.
-
Recurrent acute kidney injury is associated with delayed language development in infants with Congenital Heart Disease. Cardiol Young. 2024 Nov; 34(11):2377-2381.
-
Evaluating dynamic and predictive discrimination for recurrent event models: use of a time-dependent C-index. Biostatistics. 2024 Oct 01; 25(4):1140-1155.